Drug Prices: The Genentech Solution
“If developed nations want access to breakthrough medicines, they should have to pay full price, says Genentech Chief Executive Arthur D. Levinson. “
Amgen Opens The Secret Curtain
“The biotech leader will host analysts and investors to drum up excitement for its pipeline — and its stock. Will it work? “
Biotech uptick moves into March:
“February went out like a lion in biotechnology as filings for initial public offerings (IPOs) by three companies capped a flurry of activity in the sector. Acadia Pharmaceuticals, Alnylam Pharmaceuticals, and Ark Therapeutics announced filings in the wake of strong openings on Wall Street last month for GTx, Renovis, Corgentech, and DynaVax Technologies.”
And When ImClone’s Drug Doesn’t Work…
It’s not all roses for Erbitux: “The drug dramatically shrinks colon tumors in some patients. But in others, it has little effect — and no one knows why. “
The perilous path of biotech drugs
“The idea for a revolutionary new drug to treat allergies and asthma came to scientist Tse Wen Chang in a dream …
It would take 16 years and cost the Changs and their partners, Genentech and Novartis, hundreds of millions of dollars to develop the drug and win government approval. And it still may fall short of expectations.”
Feds to Biotech: No More Fibbing!
“A little-noted change in drug-approval procedures is a step toward avoiding more ImClone-style stock scandals “
Pfizer Wins One For Sane Patents
“What’s in a patent? For the drug industry, everything. And that’s why a court appeal that Pfizer won late Friday [Feb 13] is so important. At issue was whether a researcher must actually discover a drug in order to patent it. “
Hospital ventures into stem-cell reimplantation
“Physicians at Caritas St. Elizabeth’s Medical Center recently launched an adult stem-cell reimplantation study to battle acute cardiac disease.
Project managers at the center, which is the teaching hospital for Tufts University School of Medicine, say it is the first such program in the world.”
Cloning Creates Human Embryos
“Scientists in South Korea report that they have created human embryos through cloning and extracted embryonic stem cells, the universal cells that hold great promise for medical research.
Their goal, the scientists say, is not to clone humans but to advance understanding of the causes and treatment of disease. “
Doctors Call for Abbott Boycott on AIDS Price Hike
“A group of AIDS doctors on Tuesday called for a boycott of drugs made by Abbott Laboratories Inc. to protest the company’s recent price hike on an important HIV medicine.”
What makes this case particularly interesting is that the price hike is seen by many as a tactic to make using other company’s AIDS drugs more expensive, as they are typically prescribed with Abbott’s Novir, and compensate for profit shortfalls from the the lower than expected doses of Norvir that are being prescribed.
See also: Kaisernetwork, Natap.org.